New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For ILMN;RHHBY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
August 27, 2015
10:00 EDTILMNOn The Fly: Analyst Initiation Summary
Subscribe for More Information
07:51 EDTRHHBYRoche catching up fast to Bristol-Myers in immuno-oncology, says Jefferies
Subscribe for More Information
August 26, 2015
16:12 EDTILMNIllumina initiated with a Buy at Cantor
Target $265.
07:28 EDTILMNIllumina added to Focus List at Citi
Subscribe for More Information
August 25, 2015
05:09 EDTILMNIllumina enters oncology collaboration with Burning Rock
Subscribe for More Information
August 24, 2015
12:01 EDTRHHBYRoche buys nucleic acid purification technology from Lumora
Roche has signed a definitive asset purchase agreement with Lumora for products associated with the patent-protected Heat Elution technology for nucleic acid purification of multiple sample types including challenging formalin-fixed paraffin-embedded tumor samples. Roche plans to explore integrating this technology into its sequencing workflow solution.
08:29 EDTILMNWilliam Blair to hold a field trip
Subscribe for More Information
August 23, 2015
12:35 EDTRHHBYBiotech firms could see 'billions' in sales from new cancer drugs, Barron's says
Subscribe for More Information
August 21, 2015
09:38 EDTRHHBYUBS global healthcare analysts hold an analyst/industry conference call
Subscribe for More Information
August 19, 2015
05:36 EDTILMNIllumina price target raised to $250 from $240 at Mizuho
Subscribe for More Information
August 18, 2015
05:25 EDTILMNIllumina, Warburg Pincus, Sutter Hill form Helix, announce collaborations
Illumina (ILMN), Warburg Pincus and Sutter Hill Ventures announced that they have formed a company to empower consumers to discover insights into their own genomes through a vibrant ecosystem of high-quality content partners. The company, called Helix, is based in the San Francisco Bay Area and received financing commitments in excess of $100M. Jay Flatley, CEO of Illumina, will serve as chairman. Helix will enable individuals to acquire an unprecedented amount of genetic information by providing affordable sequencing and database services for consumer samples brought through third party partners, driving the creation of an ecosystem of consumer applications. Helix also announced two collaborations today with major partners. First, the Center for Individualized Medicine at Mayo Clinic is collaborating with Helix to develop applications initially focused on consumer education and health-related queries. As part of the collaboration, Mayo Clinic also made a strategic investment in Helix. Second, Laboratory Corporation of America Holdings (LH) will develop and offer innovative analysis and interpretation services, initially focused on medically actionable genetic conditions, to consumers through Helix's platform. Helix expects that other partners will develop applications focused on areas such as genealogy, fitness or wellness, and inherited traits to enable insights related to an individual's genetics.
August 17, 2015
05:14 EDTRHHBYGenentech reports atezolizumab pivotal Phase II study met primary endpoint
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use